Effect of optimisation to contemporary HFrEF medical therapy with sacubitril/valsartan (Entresto) and dapaglifloziN on left Ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) Imaging: the ENVI study

Introduction Heart failure with reduced ejection fraction (HFrEF) guidelines recommend ‘four pillars’ of medical therapy and device therapy if left ventricular ejection fraction (LVEF) remains ≤35% after 3 months optimum medical therapy.We conducted the first study to examine the effects of optimisa...

詳細記述

書誌詳細

出版年:	Open Heart
主要な著者:	James Shambrook, Alice Zheng, Simon Smith, Ausami Abbas, Christopher Young, Paul Haydock, Andrew Flett, Peter Cowburn, Stephen Harden, Charles Peebles, Robert Adam, Elizabeth Greenwood, Katharine Vedwan, Georgina Adam, Jane Long, Michelle Walkden, Paula Olden
フォーマット:	論文
言語:	英語
出版事項:	BMJ Publishing Group 2024-11-01
オンライン･アクセス:	https://openheart.bmj.com/content/11/2/e002933.full